ANALYSIS OF COMPLICATED CERVICAL ECTOPY CLINICAL COURSE AND RECURRENCE

Yuliya Mazur, Vira Pyrohova

Abstract


Physiological cervical ectopy (CE) is commonly found in young women, during pregnancy or intake of oral contraceptives. The complicated (pathological) CE, particularly in conditions of vaginal microbiota disturbances and human papillomavirus (HPV) infection, requires intervention, including optimal treatment and effective relapse prevention approaches.

Aim. The aim of the research was to investigate the complicated CE clinical course and recurrence features on the basis of a retrospective analysis of archival medical records in order to optimize the tactics of the complicated CE management and the relapse prevention measures.

Materials and methods. In the observational cross-sectional retrospective study using the continuous sampling method were included 740 case reports of women, who underwent inpatient treatment of gynecological pathology in Lviv Municipal Clinical First Aid Hospital in 2006–2017. The inclusion criterion was the presence of firstly diagnosed or recurrent CE. Exclusion criteria: absence of CE colposcopic or morphological confirmation, presence of physiological CE (on conditions of cytological, bacterioscopical, bacteriological and colposcopical abnormalities absence). Subsequently, three groups were formed: control group (n=150) – healthy women, who applied for a regular gynecological examination; group 1 (n=483) – women with firstly diagnosed CE; group 2 (n=257) – women with recurrent CE. Differences in mean values were considered significant with a probability level of at least 95 % (p<0.05).

Results. Patients with recurrent CE had more pregnancies (p<0.05) than the ones with firstly diagnosed CE and women of control group. The proportion of women with high parity in group 1 and group 2 was three times higher (p<0.05), than in group 3. The proportion of artificial abortions in patients of groups 1 and 2 was more than two times higher (p<0.05), than in women in the control group, group 2 patients had more miscarriages and missed miscarriages(p<0.05) in comparison to the control group. Menarche in patients with recurrent CE set in later in comparison to women of control group (p<0.05). In group 2, the proportion of women with polymenorrhea was three times higher (p<0.05), than in group 1 and control group respectively. The compromised gynecological history was more often (p<0.05) detected in group 1 and group 2, than in the control group. In patients with recurrent CE a third of gynecologic diseases in the history (32.30±2.92 %) and 23.60±1.93 % - in patients with the firstly diagnosed CE were pelvic inflammatory diseases, significantly (p<0.05) higher in comparison to the control group (3.33±1.47 %). Almost half of patients in group 1 (48.25±2.27 %) and group 2 (47.84±3.13 %) had the history of frequent infectious diseases, this indicator was significantly (p<0.05) higher in comparison to the control group (24.67±3.52 %). In patients with recurrent CE chronic diseases of different etiology were diagnosed more often (p<0.05) - their share made up 8.24±1.72 %, while in patients with firstly diagnosed CE - 4.33±0.92 %, in women of the control group - 1.33±0.94 %.The firstly diagnosed CE was more frequent (in comparison to recurrent CE) (p<0.001) characterized by asymptomatic course, whereas about half of patients with recurrent CE (46.69±3.11 %) presented with different complaints. Cytological indicators of cervicitis were found more often in patients with firstly diagnosed and recurrent CE, than in women of control group, as well as vaginal candidosis (p<0.05). Patients with recurrent CE more often (p<0.05) underwent diathermoconization (24.12±2.67 %) and cryodestruction of the cervix (8.17±1.71 %) in comparison to patients of group 1. The most often performed treatment method in patients of both groups was diathermoconization. Treatment methods aimed to restore the hormonal balance, to normalize the state of vaginal microbiota were rarely found in both group 1 and 2, drugs that affect the reparation and regeneration of the epithelium have not been used in any case.

Conclusions. Recurrent symptomatic complicated CE should be interpreted as a complex problem that requires a multi-polar approach aimed at hormonal homeostasis, local immunity, and vaginal biocenosis normalizing. These measures should precede invasive treatment and further create optimal conditions for regeneration of the cervix.


Keywords


recurrent cervical ectopy; clinical course; treatment; prevention

Full Text:

PDF

References


Baseman, J. G., Koutsky, L. A. (2005). The epidemiology of human papillomavirus infections. Journal of Clinical Virology, 32, 16–24. doi: 10.1016/j.jcv.2004.12.008

Lee, V., Tobin, J. M., Foley, E. (2006). Relationship of cervical ectopy to chlamydia infection in young women. Journal of Family Planning and Reproductive Health Care, 32 (2), 104–106. doi: 10.1783/147118906776276440

Hwang, L. Y., Ma, Y., Shiboski, S. C., Farhat, S., Jonte, J., Moscicki, A.-B. (2012). Active Squamous Metaplasia of the Cervical Epithelium Is Associated With Subsequent Acquisition of Human Papillomavirus 16 Infection Among Healthy Young Women. Journal of Infectious Diseases, 206 (4), 504–511. doi: 10.1093/infdis/jis398

Govsejev, D. A., Skorbach, E. I., Dynnik, A. A. (2014). The effectiveness of current diagnostic approaches to the problem of nonmalignant pathology of the cervix in women of reproductive age. Medicine today and tomorrow, 2/3, 128–133.

Critchlow, C. W., Wlner-Hanssen, P., Eschenbach, D. A., Kiviat, N. B., Koutsky, L. A., Stevens, C. E., Holmes, K. K. (1995). Determinants of cervical ectopia and of cervicitis: Age, oral contraception, specific cervical infection, smoking, and douching. American Journal of Obstetrics and Gynecology, 173 (2), 534–543. doi: 10.1016/0002-9378(95)90279-1

Collier, A. C., Handsfield, H. H., Ashley, R., Roberts, P. L., DeRouen, T., Meyers, J. D., Corey, L. (1995). Cervical But Not Urinary Excretion Of Cytomegalovirus Is Related To Sexual Activity And Contraceptive Practices In Sexually Active Women. Journal of Infectious Diseases, 171 (1), 33–38. doi: 10.1093/infdis/171.1.33

Plourde, P. J., Pepin, J., Agoki, E., Ronald, A. R., Ombette, J., Tyndall, M. et. al. (1994). Human Immunodeficiency Virus Type 1 Seroconversion in Women with Genital Ulcers. Journal of Infectious Diseases, 170 (2), 313–317. doi: 10.1093/infdis/170.2.313

Venkatesh, K. K., Cu-Uvin, S. (2012). Assessing the Relationship Between Cervical Ectopy and HIV Susceptibility: Implications for HIV Prevention in Women. American Journal of Reproductive Immunology, 69, 68–73. doi: 10.1111/aji.12029

Von Knebel Doeberitz, M. (2002). New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. European Journal of Cancer, 38 (17), 2229–2242. doi: 10.1016/s0959-8049(02)00462-8

Doorbar, J. (2006). Molecular biology of human papillomavirus infection and cervical cancer. Clinical Science, 110 (5), 525–541. doi: 10.1042/cs20050369

Bruni, L., Diaz, M., Castellsague, X., Ferrer, E., Bosch, F. X., de Sanjose, S. (2010). Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings. The Journal of Infectious Diseases, 202 (12), 1789–1799. doi: 10.1086/657321

Castle, P. E., Jeronimo, J., Schiffman, M., Herrero, R., Rodriguez, A. C., Bratti, M. C. et. al. (2006). Age-Related Changes of the Cervix Influence Human Papillomavirus Type Distribution. Cancer Research, 66 (2), 1218–1224. doi: 10.1158/0008-5472.can-05-3066

Rocha-Zavaleta, L., Yescas, G., Cruz, R. M., Cruz-Talonia, F. (2003). Human papillomavirus infection and cervical ectopy. International Journal of Gynecology & Obstetrics, 85 (3), 259–266. doi: 10.1016/j.ijgo.2003.10.002

Monroy, O. L., Aguilar, C., Lizano, M., Cruz-Talonia, F., Cruz, R. M., Rocha-Zavaleta, L. (2010). Prevalence of human papillomavirus genotypes, and mucosal IgA anti-viral responses in women with cervical ectopy. Journal of Clinical Virology, 47 (1), 43–48. doi: 10.1016/j.jcv.2009.10.008

Audirac-Chalifour, A., Torres-Poveda, K., Bahena-Roman, M., Tellez-Sosa, J., Martinez-Barnetche, J., Cortina-Ceballos, B. et. al. (2016). Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study. PLOS ONE, 11 (4), e0153274. doi: 10.1371/journal.pone.0153274

Mitra, A., MacIntyre, D. A., Lee, Y. S., Smith, A., Marchesi, J. R., Lehne, B. et. al. (2015). Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Scientific Reports, 5 (1). doi: 10.1038/srep16865

Nayar, R., Wilbur, D. C. et. al. (2015). The Bethesda System for Reporting Cervical Cytology. Definitions, Criteria, and Explanatory Notes. Cham: Springer, 342. doi: 10.1007/978-3-319-11074-5

Kleppa, E., Holmen, S. D., Lillebo, K., Kjetland, E. F., Gundersen, S. G., Taylor, M. et. al. (2014). Cervical ectopy: associations with sexually transmitted infections and HIV. A cross-sectional study of high school students in rural South Africa. Sexually Transmitted Infections, 91 (2), 124–129. doi: 10.1136/sextrans-2014-051674

Cekmez, Y., Sanlikan, F., Gocmen, A., Vural, A., Turkmen, S. B. (2015). Is Cryotherapy Friend or Foe for Symptomatic Cervical Ectopy? Medical Principles and Practice, 25 (1), 8–11. doi: 10.1159/000441433

Narin, R., Narin, M. A., Nazik, H. et. al. (2015). The importance of size of cervical ectopy to predict postcoital bleeding: is there any cut-off value? Clinical and Experimental Obstetrics and Gynecology, 42 (2), 195–198.

Singh, V., Parashari, A., Satyanarayana, L., Sodhani, P., Gupta, M. M., Sehgal, A. (1999). Biological behavior and etiology of inflammatory cervical smears. Diagnostic Cytopathology, 20 (4), 199–202. doi: 10.1002/(sici)1097-0339(199904)20:4<199::aid-dc3>3.0.co;2-2

Sanchez, A., Rivera, A., Castillo, F., Ortiz, S. (2012). Cervical erosion as result of infectious vaginitis. European Journal of Experimental Biology, 2 (5), 1659–1663.

Trejo, J., Hernandez, B., Carrasco, J. et. al. (2003). Guia clinica para el diagnostico, tratamiento y prevencion de cervicovaginitis por bacterias, Trichomonas y Candida. Revista Medica del Instituto Mexicano del Seguro Social, 41, 71–76.




DOI: http://dx.doi.org/10.21303/2504-5679.2018.00563

Refbacks

  • There are currently no refbacks.




Copyright (c) 2018 Yuliya Mazur, Vira Pyrohova

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)